PROSTATE CANCER

Salvage radiotherapy: a new standard of care

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

Original articles

  1. Kneebone, A. et al. Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial. Lancet Oncol. 21, 1331–1340 (2020)

    Article  Google Scholar 

  2. Sargos, P. et al. Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial. Lancet Oncol. 21, 1341–1352 (2020)

    Article  Google Scholar 

  3. Parker, C. C. et al. Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial. Lancet https://doi.org/10.1016/S0140-6736(20)31553-1 (2020)

    Article  PubMed  Google Scholar 

Related article

  1. Vale, C. L. et al. Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data. Lancet https://doi.org/10.1016/S0140-6736(20)31952-8 (2020)

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Peter Sidaway.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sidaway, P. Salvage radiotherapy: a new standard of care. Nat Rev Clin Oncol (2020). https://doi.org/10.1038/s41571-020-00443-3

Download citation

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing